Stock OPK OPKO HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OPKO Health, Inc.

Equities

OPK

US68375N1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
1.23 USD -1.60% Intraday chart for OPKO Health, Inc. -1.60% -18.54%
Mar. 28 Laboratory Corp of America to Acquire BioReference's Diagnostics Business Select Assets MT
Mar. 20 Entera Bio Announces Robust Pharmacokinetic Data for First-In-Class Oral Glp-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome CI

Evolution of the average Target Price on OPKO Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0fb1ec.pcTQthbT7bDPM-CqI6pVGp2Gh1dF_SR9_2bk5IEyXKE.ybW0-Vriq-m_adfdfP8gVtPW9hlyiW0rqzS2qfVRM-DxrePnUoG85fgK1A~2f471daceb5d129b85a8002001382c45

Analyst Recommendations on OPKO Health, Inc.

Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating MT
Barrington Upgrades OPKO Health to Outperform From Market Perform, Price Target is $2 MT
The American consumer comes to the rescue Our Logo
HC Wainwright Initiates Coverage on OPKO Health With Buy Rating, $3 Price Target MT
Piper Sandler Adjusts OPKO Health's Price Target to $4 From $5, Reiterates Overweight Rating MT
Piper Sandler Adjusts OPKO Health's Price Target to $5 From $6, Reiterates Overweight Rating MT
Barrington Research Downgrades Opko Health Inc to Market Perform From Outperform MT
OPKO HEALTH : Barrington Adjusts Price Target on Opko Health to $6 From $8 on Lab Unit Revenue Decline, Maintains Outperform Rating MT
OPKO HEALTH : Ladenburg Thalmann Starts Opko Health at Buy With $7 Price Target MT
OPKO Health, Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Revenue Guidance for Third Quarter of 2018; Reaffirms Tax Rate Guidance for the Full Year 2018 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.23 USD
Average target price
4.25 USD
Spread / Average Target
+245.53%
High Price Target
8.5 USD
Spread / Highest target
+591.06%
Low Price Target
1.5 USD
Spread / Lowest Target
+21.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering OPKO Health, Inc.

Barrington Research
HC Wainwright
Piper Sandler
Ladenburg Thalmann

Ratings for OPKO Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OPK Stock
  4. Consensus OPKO Health, Inc.